Abigail Anne Risic

Array ( [id] => 6721287 [patent_doc_number] => 20030054976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Tyrosine-and tryptophan-containing peptides as antioxidants' [patent_app_type] => new [patent_app_number] => 10/148557 [patent_app_country] => US [patent_app_date] => 2002-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 2292 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20030054976.pdf [firstpage_image] =>[orig_patent_app_number] => 10148557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 707857 [patent_doc_number] => 07060677 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-13 [patent_title] => 'Antimicrobial activity of the first cationic cluster of human lactoferrin' [patent_app_type] => utility [patent_app_number] => 10/130180 [patent_app_country] => US [patent_app_date] => 2000-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13649 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060677.pdf [firstpage_image] =>[orig_patent_app_number] => 10130180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261671 [patent_doc_number] => 06664233 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Combination therapy including 9-nitro-20(S)-camptothecin and bleomycin' [patent_app_type] => B1 [patent_app_number] => 09/709967 [patent_app_country] => US [patent_app_date] => 2000-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4037 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664233.pdf [firstpage_image] =>[orig_patent_app_number] => 09709967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1165562 [patent_doc_number] => 06759515 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'Compositions and methods for the therapy and diagnosis of prostate cancer' [patent_app_type] => B1 [patent_app_number] => 09/679426 [patent_app_country] => US [patent_app_date] => 2000-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 68633 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759515.pdf [firstpage_image] =>[orig_patent_app_number] => 09679426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261663 [patent_doc_number] => 06664231 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Anti-fungal peptides' [patent_app_type] => B1 [patent_app_number] => 09/677664 [patent_app_country] => US [patent_app_date] => 2000-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 38889 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664231.pdf [firstpage_image] =>[orig_patent_app_number] => 09677664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073776 [patent_doc_number] => 06838441 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-04 [patent_title] => 'Albumin for treating meconium aspiration syndrome' [patent_app_type] => utility [patent_app_number] => 10/110182 [patent_app_country] => US [patent_app_date] => 2000-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2991 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838441.pdf [firstpage_image] =>[orig_patent_app_number] => 10110182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 483629 [patent_doc_number] => 07220824 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-22 [patent_title] => 'Integrin-mediated drug targeting' [patent_app_type] => utility [patent_app_number] => 10/070208 [patent_app_country] => US [patent_app_date] => 2000-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49405 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 255 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220824.pdf [firstpage_image] =>[orig_patent_app_number] => 10070208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1271682 [patent_doc_number] => 06653451 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Soybean products with improved carbohydrate composition and soybean plants' [patent_app_type] => B1 [patent_app_number] => 09/642337 [patent_app_country] => US [patent_app_date] => 2000-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 30272 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653451.pdf [firstpage_image] =>[orig_patent_app_number] => 09642337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7609801 [patent_doc_number] => 06998388 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-14 [patent_title] => 'High density lipoprotein against organ dysfunction following haemorrhagic shock' [patent_app_type] => utility [patent_app_number] => 10/069157 [patent_app_country] => US [patent_app_date] => 2000-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 4110 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/998/06998388.pdf [firstpage_image] =>[orig_patent_app_number] => 10069157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 542971 [patent_doc_number] => 07169759 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-01-30 [patent_title] => 'Tetrapeptide inhibitors of β-secretase' [patent_app_type] => utility [patent_app_number] => 09/594667 [patent_app_country] => US [patent_app_date] => 2000-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14873 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169759.pdf [firstpage_image] =>[orig_patent_app_number] => 09594667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 843182 [patent_doc_number] => 07387771 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-06-17 [patent_title] => 'Method for producing an injectable medicament preparation' [patent_app_type] => utility [patent_app_number] => 09/980266 [patent_app_country] => US [patent_app_date] => 2000-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 6940 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/387/07387771.pdf [firstpage_image] =>[orig_patent_app_number] => 09980266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1240631 [patent_doc_number] => 06686443 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-03 [patent_title] => 'Chemical reagents for formation of disulfide bonds in peptides' [patent_app_type] => B1 [patent_app_number] => 09/579883 [patent_app_country] => US [patent_app_date] => 2000-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 0 [patent_no_of_words] => 10098 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686443.pdf [firstpage_image] =>[orig_patent_app_number] => 09579883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1046833 [patent_doc_number] => 06864228 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-08 [patent_title] => 'Use of bisphosphonates for the treatment of osteogenesis imperfecta' [patent_app_type] => utility [patent_app_number] => 09/570275 [patent_app_country] => US [patent_app_date] => 2000-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 6405 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/864/06864228.pdf [firstpage_image] =>[orig_patent_app_number] => 09570275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 988194 [patent_doc_number] => 06921749 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-07-26 [patent_title] => 'Polypeptides derived from endostatin exhibiting antiangiogenic activity' [patent_app_type] => utility [patent_app_number] => 09/958489 [patent_app_country] => US [patent_app_date] => 2000-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4369 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/921/06921749.pdf [firstpage_image] =>[orig_patent_app_number] => 09958489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 715812 [patent_doc_number] => 07053044 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-30 [patent_title] => 'Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant' [patent_app_type] => utility [patent_app_number] => 09/926009 [patent_app_country] => US [patent_app_date] => 2000-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5419 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/053/07053044.pdf [firstpage_image] =>[orig_patent_app_number] => 09926009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1383599 [patent_doc_number] => 06551992 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Stable insulin formulations' [patent_app_type] => B1 [patent_app_number] => 09/450794 [patent_app_country] => US [patent_app_date] => 1999-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6875 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/551/06551992.pdf [firstpage_image] =>[orig_patent_app_number] => 09450794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 892156 [patent_doc_number] => 07345021 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-03-18 [patent_title] => 'Method for PR-39 peptide regulated stimulation of angiogenesis' [patent_app_type] => utility [patent_app_number] => 09/426011 [patent_app_country] => US [patent_app_date] => 1999-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 23 [patent_no_of_words] => 10387 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/345/07345021.pdf [firstpage_image] =>[orig_patent_app_number] => 09426011 [rel_patent_id] =>[rel_patent_doc_number] =>)